could cause cymbalta anxiety heartbeat irregularities.Special warnings about CymbaltaIn clinical studies, antidepressants increased cymbalta anxiety risk of suicidal thinking and behavior in children and adolescents with depression and other psychiatric disorders. Anyone considering the use of Cymbalta or cymbalta anxiety other.

company, signed a long-term agreement jointly to develop and commercialize duloxetine hydrochloride.In Japan, duloxetine has been cymbalta anxiety developed with the pharmaceutical company Shionogi Ltd. cymbalta anxiety depression since 1992, cymbalta anxiety signing a license agreement with Eli Lilly. As of January 2007, Shionogi had already received cymbalta anxiety for the indication of depression, but is still conducting additional Phase III trials. For the treatment of pain cymbalta anxiety to cymbalta anxiety peripheral neuropathy, Shionogi said it and Eli Lilly Japan cymbalta anxiety will work together on the development as well as marketing. For this use, the cymbalta anxiety is now going through Phase II clinical trials.HypersensitivityNausea, somnolence, insomnia, and cymbalta anxiety are the main side effects, reported by about 10 to 20 percent of patients.[8]In a trial for mild major depressive disorder (MDD), the most commonly reported treatment-emergent adverse events among cymbalta anxiety patients were nausea cymbalta anxiety dry cymbalta anxiety (22.7%), headache cymbalta anxiety and dizziness (18.7%), and.

known as tricyclics, such as amitriptylineAntidepressants that raise serotonin.